Genetic Predisposition for the Development of Lamotrigine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: a Systematic Review and Meta-Analysis
- 1 March 2023
- journal article
- review article
- Published by Taylor & Francis in Personalized Medicine
- Vol. 20 (2) , 201-213
Abstract
Studies report an association between the expression of HLA alleles and lamotrigine (LTG)-induced Stevens–Johnson syndrome (SJS). This systematic review and meta-analysis evaluates the association ...Keywords
This publication has 36 references indexed in Scilit:
- Systemic review on drug related hospital admissions – A pubmed based searchSaudi Pharmaceutical Journal, 2015
- Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in SingaporeNeurology, 2012
- Association between HLA and Stevens–Johnson Syndrome Induced by Carbamazepine in Southern Han Chinese: Genetic Markers besides B*1502?Basic & Clinical Pharmacology & Toxicology, 2012
- Carbamazepine and phenytoin induced Stevens‐Johnson syndrome is associated with HLA‐B*1502 allele in Thai populationEpilepsia, 2008
- Carbamazepine, HLA-B*1502 and Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: US FDA RecommendationsPharmacogenomics, 2008
- A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugsPharmacogenetics and Genomics, 2008
- HLA-B∗1502–bound peptides: Implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndromeJournal of Allergy and Clinical Immunology, 2007
- A marker for Stevens-Johnson syndrome …: ethnicity mattersThe Pharmacogenomics Journal, 2006
- A marker for Stevens–Johnson syndromeNature, 2004
- Pemphigus vulgaris in Jewish patients is associated with HLA-A region genesHuman Immunology, 2003